Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josephin Wagner

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
ACS Chemical Neuroscience|November 14, 2022
<i>PCSK9</i> Base Editing Therapeutics and Ischemic StrokeJosephin Wagner, Andrew S Bell, Falk W Lohoff
ACS Chemical Neuroscience|July 9, 2026
PCSK9 as an Emerging Target for Cerebrovascular Dysfunction and Neuroinflammation in Ischemic StrokeCarolina Vela, Josephin Wagner, Pal Pacher, et al.
Neuroscience and Biobehavioral Reviews|April 5, 2023
Proprotein convertase subtilisin/kexin type 9 (PCSK9) in the central nervous systemAndrew S Bell, Josephin Wagner, Daniel B Rosoff, et al.
Journal of the American College of Cardiology|August 11, 2022
Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive FunctionDaniel B Rosoff, Andrew S Bell, Jeesun Jung, et al.
Nature Human Behaviour|November 11, 2024
A multi-omics Mendelian randomization study identifies new therapeutic targets for alcohol use disorder and problem drinkingDaniel B Rosoff, Josephin Wagner, Andrew S Bell, et al.
Journal of the American Heart Association|October 26, 2022
Comparing the Relationships of Genetically Proxied PCSK9 Inhibition With Mood Disorders, Cognition, and Dementia Between Men and Women: A Drug-Target Mendelian Randomization StudyAndrew S Bell, Daniel B Rosoff, Lucas A Mavromatis, et al.
Nature Communications|April 19, 2023
Multi-omic underpinnings of epigenetic aging and human longevityLucas A Mavromatis, Daniel B Rosoff, Andrew S Bell, et al.
Alcohol, Clinical & Experimental Research|March 28, 2025
Alcohol and aging: Next-generation epigenetic clocks predict biological age acceleration in individuals with alcohol use disorderTyler A Perlstein, Jeesun Jung, Alexandra C Wagner, et al.
Translational Stroke Research|February 12, 2018
Interleukin 6-Mediated Endothelial Barrier Disturbances Can Be Attenuated by Blockade of the IL6 Receptor Expressed in Brain Microvascular Endothelial CellsKinga G Blecharz-Lang, Josephin Wagner, Alexa Fries, et al.
Addiction Biology|November 29, 2023
Multi-omics analysis of alcohol effects on the liver in young and aged miceLea Zillich, Josephin Wagner, Rachel H McMahan, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
ACS Chemical Neuroscience|November 14, 2022
<i>PCSK9</i> Base Editing Therapeutics and Ischemic StrokeJosephin Wagner, Andrew S Bell, Falk W Lohoff
ACS Chemical Neuroscience|July 9, 2026
PCSK9 as an Emerging Target for Cerebrovascular Dysfunction and Neuroinflammation in Ischemic StrokeCarolina Vela, Josephin Wagner, Pal Pacher, et al.
Neuroscience and Biobehavioral Reviews|April 5, 2023
Proprotein convertase subtilisin/kexin type 9 (PCSK9) in the central nervous systemAndrew S Bell, Josephin Wagner, Daniel B Rosoff, et al.
Journal of the American College of Cardiology|August 11, 2022
Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive FunctionDaniel B Rosoff, Andrew S Bell, Jeesun Jung, et al.
Nature Human Behaviour|November 11, 2024
A multi-omics Mendelian randomization study identifies new therapeutic targets for alcohol use disorder and problem drinkingDaniel B Rosoff, Josephin Wagner, Andrew S Bell, et al.
Journal of the American Heart Association|October 26, 2022
Comparing the Relationships of Genetically Proxied PCSK9 Inhibition With Mood Disorders, Cognition, and Dementia Between Men and Women: A Drug-Target Mendelian Randomization StudyAndrew S Bell, Daniel B Rosoff, Lucas A Mavromatis, et al.
Nature Communications|April 19, 2023
Multi-omic underpinnings of epigenetic aging and human longevityLucas A Mavromatis, Daniel B Rosoff, Andrew S Bell, et al.
Alcohol, Clinical & Experimental Research|March 28, 2025
Alcohol and aging: Next-generation epigenetic clocks predict biological age acceleration in individuals with alcohol use disorderTyler A Perlstein, Jeesun Jung, Alexandra C Wagner, et al.
Translational Stroke Research|February 12, 2018
Interleukin 6-Mediated Endothelial Barrier Disturbances Can Be Attenuated by Blockade of the IL6 Receptor Expressed in Brain Microvascular Endothelial CellsKinga G Blecharz-Lang, Josephin Wagner, Alexa Fries, et al.
Addiction Biology|November 29, 2023
Multi-omics analysis of alcohol effects on the liver in young and aged miceLea Zillich, Josephin Wagner, Rachel H McMahan, et al.
Pageof 3